Stockpolly
Search
EVAX · NASDAQ · Biotechnology

Evaxion (ADR) (EVAX)

Decodes immune biology with AI to build vaccine candidates and partner programs.

$3.00
Pre-market−0.09 (−3.05%)
At close$3.10(+3.86%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000030007000
Gross profit000030007000
644554444444
Research & development323332223322
322222221122
General & administrative322222221120
Other expenses000000000000
Operating income−6−4−4−5−2−4−4−43−4−4−4
005−2002−11−200
Interest income006001203−500
Interest expense000000001−100
Other non-operating income00−6202−20−3400
Income before tax−6−51−6−2−4−2−54−6−4−4
Income tax expense000000000000
Net income from continuing operations−6−51−6−2−4−2−55−6−4−4
Other adjustments000000000000
Net income−6−51−6−2−4−2−55−6−4−4
EPS, basic−$8.20−$6.60$1.04−$4.60−$1.40−$3.40−$1.43−$4.40$4.20−$0.89−$0.44−$9.00
EPS, diluted−$8.20−$6.60$1.04−$4.60−$1.40−$3.40−$0.50−$4.40$4.20−$0.89−$0.44−$9.00
Weighted average shares, basic111111111680
Weighted average shares, diluted111111111680
EBITDA−6−41−6−2−6−1−56−8−4−4
Depreciation & amortization000000000000
EBIT−6−51−6−2−6−1−56−8−4−4